Single-Dose Pharmacokinetics and Preliminary Safety Assessment with Use of CBD-Rich Hemp Nutraceutical in Healthy Dogs and Cats

SIMPLE SUMMARY: The use of cannabidiol (CBD)-rich hemp-based nutraceuticals is increasing in dogs and cats for disorders related to anxiety, seizures, cancer and pain. To date, there is little information related to appropriate dosing or long-term effects on serum chemistry or complete blood counts...

Descripción completa

Detalles Bibliográficos
Autores principales: Deabold, Kelly A., Schwark, Wayne S., Wolf, Lisa, Wakshlag, Joseph J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826847/
https://www.ncbi.nlm.nih.gov/pubmed/31635105
http://dx.doi.org/10.3390/ani9100832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826847/
https://www.ncbi.nlm.nih.gov/pubmed/31635105
http://dx.doi.org/10.3390/ani9100832

Ejemplares similares